目录号 | 产品详情 | 靶点 | |
---|---|---|---|
T1468 | COX Endogenous Metabolite | ||
Lornoxicam (Chlortenoxicam) 是一种新型非甾体抗炎药,是高活性 COX-1 和 COX-2 抑制剂,IC50 分别为 5 和 8 nM。 | |||
T1002 | Retinoid Receptor COX | ||
Etodolac (AY-24236) 是一种吡喃羧酸和非甾体抗炎药,具有解热和镇痛活性,对 COX 的 IC50为53.5 nM。 | |||
T0219 | COX | ||
Valdecoxib (SC 65872) 是可口服的高选择性 COX-2抑制剂,对 COX-2 和 COX-1 的 IC50值分别为 5 nM 和 140 μM,可用于治疗骨关节炎、类风湿性关节炎以及痛经和经期症状。 | |||
T6424 | COX | ||
Bromfenac Sodium (AHR 10282R) 是可口服的COX 抑制剂,抑制COX-1和COX-2的IC50值分别为 5.56 和 7.45 nM。它是溴化非甾体类抗炎药,通常用于白内障的术后炎症和疼痛以及假晶状体囊状黄斑水肿的研究。 | |||
T68155 | Prostaglandin Receptor LTR | ||
Tebufelone 是一种体外高效的CO 抑制剂 ,是一种新型的非甾体抗炎药(NSAID),属于二叔丁基苯酚(DTBP)类,在各种动物模型中显示出强大的抗炎、镇痛和抗网膜炎特性。Tebufelone 能有效地抑制前列腺素(PGE2)的形成,阻止大鼠巨噬细胞(IC50 = 20 microM)和人类全血(IC50 = 22 microM)中脂氧酶途径的产物[白三烯(LTB4)]的体外形成。 | |||
T0839 | Apoptosis COX MRP | ||
Ketoprofen (RP-19583) 是一种非甾体抗炎剂,能够有效地抑制COX 的活性,在人血单核细胞中,对 COX-1 和 COX-2 的IC50值分别为 2 nM 和 26 nM。 | |||
T2403 | COX | ||
Bromfenac sodium hydrate (Bromfenac monosodium salt sesquihydrate) 是一种可口服的 COX 抑制剂,抑制 COX-1和COX-2的IC50值分别为 5.56 和 7.45 nM。它是一种溴化非甾体类抗炎药,有用于白内障的术后炎症和疼痛以及假晶状体囊状黄斑水肿的研究。 | |||
T70843 | |||
Orazipone inhibits cytokine production and histamine release; an NSAID. | |||
T31817 | |||
Flumizole is a non-steroidal anti-inflammatory drug (NSAID) that works by inhibiting the enzyme cyclocxygenase (COX). | |||
T20869 | |||
Flunixin is a nonsteroidal anti-inflammatory drug (NSAID), antipyretic, and analgesic used in pigs, horses, and cattle. |
目录号 | 产品名/同用名 | 种属 | 表达系统 | ||
---|---|---|---|---|---|
TMPK-01243 | GDF-15 Protein, Rat, Recombinant (His) | Rat | E. coli | ||
Growth Differentiation Factor 15 (GDF15), also known as NSAID activated gene-1 (NAG-1), is associated with a large number of biological processes and diseases, including cancer and obesity. GDF15 is synthesized as pro-GDF15, is dimerized, and is cleaved and secreted into the circulation as a mature dimer GDF15.
|
|||||
TMPK-00569 | GDF-15 Protein, Canine, Recombinant (His) | Canine | E. coli | ||
Growth Differentiation Factor 15 (GDF15), also known as NSAID activated gene-1 (NAG-1), is associated with a large number of biological processes and diseases, including cancer and obesity. GDF15 is synthesized as pro-GDF15, is dimerized, and is cleaved and secreted into the circulation as a mature dimer GDF15.
|
|||||
TMPK-00196 | GDF-15 Protein, Human, Recombinant (His & Avi), Biotinylated | Human | E. coli | ||
Growth Differentiation Factor 15 (GDF15), also known as NSAID activated gene-1 (NAG-1), is associated with a large number of biological processes and diseases, including cancer and obesity. GDF15 is synthesized as pro-GDF15, is dimerized, and is cleaved and secreted into the circulation as a mature dimer GDF15.
|